About Technipro-PulmoMed


Technipro Marketing was founded in 1984 to identify, develop and market high-quality specialised products for under-served medical markets.

Technipro’s traditional focus has been in niche areas of respiratory medicine, especially comprehensive disease management for cystic fibrosis & respiratory function monitoring.

In July 2010, Technipro was proud to announce that it divided its business operations into two companies comprising of Technipro-PulmoMed Pty Ltd (ABN 54 002 730 421) and it’s subsidiary, SMR-Tech Pty Ltd (ABN  12 103 215 603). The subdivision is due to the expansion of our business activities which now include product lines beyond the traditional Technipro cystic fibrosis activities.

For information on SMR Tech, please visit, www.smrtech.com.au.

Technipro-PulmoMed’s focus

Our focus is marketing a portfolio of world renowned products for comprehensive management of cystic fibrosis, bronchiectasis, chronic respiratory diseases & Pancreatic enzyme deficiencies.

Our Team

Managing Director Ed van Riet
Customer Service Manager Roland Eisenkolb
Administration Manager Jim King
Product Specialist (NSW, ACT, Qld) Matthew Murray
Product Specialist (Vic, Tas, SA & WA) Mat van Heerden


Technipro-PulmoMed is an exclusive distributor for a range of leading world renowned products including the innovative Pari® aerosol medication delivery products, pharmaceuticals for cystic fibrosis such as Panzytrat® (pancreatic enzymes), VitABDECK multi-vitamins, and PMD’s Spiro PD personal spirometer for easy, accurate lung function measurement, anytime, anywhere.

Distinctive Competence

A streamlined organisation, with tight marketing concentration, allows Technipro-PulmoMed to cost effectively bring new and improved products to the market.